Impact of KRAS mutations on adjuvant carboplatin/paclitaxel in surgically resected stage IB NSCLC: CALGB 9633
- Citation:
- J Clin Oncol vol 28 (15s) abstr 7008
- Meeting Instance:
- ASCO 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 718
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Respiratory
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- M. Capelletti X. F. Wang L. Gu S. L. Graziano R. A. Kratzke G. M. Strauss M. Maddaus M. R. Green E. E. Vokes P. A. Janne
- Networks:
- Study
- CALGB-9633
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: